The strange world of organ preservation is spawning new tech firms. OrganOx has added impetus to the industry with a $142mn ...

A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

Getting your Trinity Audio player ready... “If you know, you know,”—a phrase commonly used to refer to something that is understood or known by a select group of people. It is a phrase that applies to ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- OrganOx Ltd., a medical technology company developing innovative solutions for organ preservation, and eGenesis, Inc., a biotechnology company developing ...